VYNT

Vyant Bio (VYNT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VYNT
DataOraFonteTitoloSimboloCompagnia
26/12/202315:15GlobeNewswire Inc.Vyant Bio Provides Update on Winddown ActivitiesNASDAQ:VYNTVyant Bio Inc
01/11/202316:45GlobeNewswire Inc.Vyant Bio Announces Stockholder Approval of Plan of DissolutionNASDAQ:VYNTVyant Bio Inc
24/10/202322:00GlobeNewswire Inc.Vyant Bio Announces Completion of StemoniX Asset SaleNASDAQ:VYNTVyant Bio Inc
19/10/202317:45GlobeNewswire Inc.Vyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
11/10/202317:45GlobeNewswire Inc.Vyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
28/09/202317:45GlobeNewswire Inc.Vyant Bio Announces Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
31/07/202323:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VYNTVyant Bio Inc
15/05/202314:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:VYNTVyant Bio Inc
12/05/202314:00GlobeNewswire Inc.Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
10/05/202314:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VYNTVyant Bio Inc
04/05/202322:33Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:VYNTVyant Bio Inc
04/05/202322:30GlobeNewswire Inc.Vyant Bio Announces Filing of Form 25 for Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
24/04/202322:50GlobeNewswire Inc.Vyant Bio Announces Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
28/03/202312:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VYNTVyant Bio Inc
24/03/202314:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VYNTVyant Bio Inc
24/03/202313:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VYNTVyant Bio Inc
03/02/202312:00GlobeNewswire Inc.Vyant Bio Commences a Cash Preservation Plan Including a Reduction in ForceNASDAQ:VYNTVyant Bio Inc
19/01/202322:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VYNTVyant Bio Inc
04/01/202322:15GlobeNewswire Inc.Vyant Bio Engages LifeSci Capital to Explore Strategic AlternativesNASDAQ:VYNTVyant Bio Inc
17/11/202212:20TipRanksAnalysts Are Bullish on These Healthcare Stocks: Vyant Bio (VYNT), Cybin (CYBN)NASDAQ:VYNTVyant Bio Inc
16/11/202223:05GlobeNewswire Inc.Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for NeuroscienceNASDAQ:VYNTVyant Bio Inc
16/11/202222:43GlobeNewswire Inc.Vyant Bio Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:VYNTVyant Bio Inc
15/11/202214:00GlobeNewswire Inc.Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business HighlightsNASDAQ:VYNTVyant Bio Inc
14/11/202222:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VYNTVyant Bio Inc
10/11/202223:13GlobeNewswire Inc.Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at the 2022 CDKL5 Forum Hosted by the Loulou FoundationNASDAQ:VYNTVyant Bio Inc
10/11/202214:00GlobeNewswire Inc.Vyant Bio to Participate at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12-16NASDAQ:VYNTVyant Bio Inc
07/11/202215:00GlobeNewswire Inc.Vyant Bio Teams Up with the International Rett Syndrome Foundation to Host Local Viewing Party in Honor of the 3rd Annual ‘Raise a Glass for Rett Gala’NASDAQ:VYNTVyant Bio Inc
04/11/202211:10TipRanksAnalysts Are Bullish on These Healthcare Stocks: Vyant Bio (VYNT), Kymera Therapeutics (KYMR)NASDAQ:VYNTVyant Bio Inc
03/11/202214:10GlobeNewswire Inc.Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. SubsidiaryNASDAQ:VYNTVyant Bio Inc
01/11/202213:00GlobeNewswire Inc.Vyant Bio Announces One-for-Five Reverse Stock SplitNASDAQ:VYNTVyant Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VYNT
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network